- Home
- PMEC vs DTIL Comparison
PMEC vs DTIL Comparison
Compare PMEC & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- DTIL
- Stock Information
- Founded
- PMEC 1984
- DTIL 2006
- Country
- PMEC Singapore
- DTIL United States
- Employees
- PMEC N/A
- DTIL N/A
- Industry
- PMEC
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- PMEC
- DTIL Health Care
- Exchange
- PMEC Nasdaq
- DTIL Nasdaq
- Market Cap
- PMEC 56.9M
- DTIL 55.3M
- IPO Year
- PMEC 2023
- DTIL 2019
- Fundamental
- Price
- PMEC $1.87
- DTIL $4.61
- Analyst Decision
- PMEC
- DTIL Strong Buy
- Analyst Count
- PMEC 0
- DTIL 2
- Target Price
- PMEC N/A
- DTIL $47.00
- AVG Volume (30 Days)
- PMEC 244.2K
- DTIL 78.0K
- Earning Date
- PMEC 01-01-0001
- DTIL 11-03-2025
- Dividend Yield
- PMEC N/A
- DTIL N/A
- EPS Growth
- PMEC N/A
- DTIL N/A
- EPS
- PMEC N/A
- DTIL N/A
- Revenue
- PMEC $74,349,000.00
- DTIL $1,261,000.00
- Revenue This Year
- PMEC N/A
- DTIL N/A
- Revenue Next Year
- PMEC N/A
- DTIL $135.19
- P/E Ratio
- PMEC N/A
- DTIL N/A
- Revenue Growth
- PMEC 2.52
- DTIL N/A
- 52 Week Low
- PMEC $0.54
- DTIL $3.61
- 52 Week High
- PMEC $1.89
- DTIL $10.71
- Technical
- Relative Strength Index (RSI)
- PMEC 62.47
- DTIL 40.75
- Support Level
- PMEC $1.76
- DTIL $4.86
- Resistance Level
- PMEC $1.88
- DTIL $5.17
- Average True Range (ATR)
- PMEC 0.15
- DTIL 0.24
- MACD
- PMEC 0.02
- DTIL -0.03
- Stochastic Oscillator
- PMEC 96.92
- DTIL 16.18
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.